Novo Nordisk
NVO
#107
Rank
C$239.04 B
Marketcap
C$54.24
Share price
-2.70%
Change (1 day)
-19.24%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

EPS for Novo Nordisk (NVO)

EPS in 2026 (TTM): C$5.51

According to Novo Nordisk's latest financial reports the company's current EPS (TTM) is C$5.66. In 2025 the company made an earnings per share (EPS) of C$5.09 an increase over its 2024 EPS that were of C$4.69.

EPS history for Novo Nordisk from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$5.518.15%
2025C$5.098.48%
2024C$4.69
2016C$1.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.02-82.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$44.30 682.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.84-49.81%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
C$6.48 14.55%๐Ÿ‡บ๐Ÿ‡ธ USA